Does multicenter care impact the outcomes of surgical patients with gastrointestinal malignancies requiring complex multimodality therapy?
Adrienne B ShannonJulia MoYun SongEmily C PaulsonRobert E RosesDouglas L FrakerRachel R KelzJohn T MiuraGiorgos C KarakousisPublished in: Journal of surgical oncology (2020)
The use of MCC appears safe without a difference in survival and may offer significant advantages in convenience to patients as they undergo their complex oncologic care.
Keyphrases
- healthcare
- palliative care
- end stage renal disease
- ejection fraction
- newly diagnosed
- quality improvement
- peritoneal dialysis
- pain management
- prognostic factors
- type diabetes
- prostate cancer
- affordable care act
- rectal cancer
- cell therapy
- double blind
- insulin resistance
- minimally invasive
- free survival
- smoking cessation